Ranexa (Ranolazine) – Patient Information (Australia)

Ranexa is a medicine used to treat chronic (long-term) angina—a type of chest pain caused by reduced blood flow to the heart. It helps some people live more comfortably by reducing the frequency of angina attacks and improving exercise tolerance.

This page provides clear, patient-friendly information about Ranexa (ranolazine), including how it works, how it’s taken, important safety points, and common interactions. Always follow the advice of your healthcare professional and read the product information provided with your medicine.

Basic product information

• Generic name: Ranolazine
• Brand name: Ranexa
• Common strengths (brands vary by supply): Often available as extended-release tablets
• How it’s taken: By mouth, usually twice daily (extended-release dosing)
• Medicine type: Anti-anginal (works to improve heart-related symptoms)

Note: The exact tablet strengths and packaging details can differ. Your pharmacist or prescriber can confirm what’s available for you in Australia.

How Ranexa works (mechanism of action)

Ranexa (ranolazine) works by targeting the electrical and energy-related processes in heart cells.

• Reduces abnormal electrical activity: It affects ion currents within heart cells, which can help stabilise heart rhythm at the cellular level.
• Improves efficiency under low-oxygen conditions: Ranolazine helps the heart make better use of oxygen during stress, such as when blood flow is limited.
• Helps reduce angina frequency: Over time, this can translate into fewer episodes of chest pain and improved tolerance of physical activity.

Ranexa is typically used for stable angina (also called chronic angina). It is not intended for immediate relief of sudden chest pain in the way some “rescue” medicines are.

What Ranexa is used for (indications)

In Australia, ranolazine is used to manage chronic (stable) angina in adults, particularly when symptoms persist despite other therapies or when certain options are not suitable.

Healthcare professionals may consider Ranexa when:

• Angina is stable and long-term
• Chest pain continues despite treatment with other anti-anginal medicines, or combinations may be needed
• There are specific reasons to consider a non-traditional anti-anginal approach

Typical timing and how to take Ranexa

Ranexa is usually supplied as extended-release tablets. This means it releases medicine slowly over time to maintain steady levels in the body.

• Common schedule: Twice daily (e.g., morning and evening)
• Consistency matters: Try to take doses at about the same times each day
• Swallow whole: Do not crush, chew, or break extended-release tablets unless instructed otherwise
• If you miss a dose: Take it when you remember unless it is close to the next dose. Do not double up

If your starting dose is gradually increased, follow your clinician’s plan. Dose titration can help reduce side effects such as dizziness or nausea and improve long-term tolerance.

Dosing: what to expect

Dose depends on your condition, age, other medicines, and how well you tolerate Ranexa.

General dosing principles

• Start low and adjust: Many people begin on a lower dose and may be increased after monitoring.
• Special caution in liver or kidney issues: Dosing may be adjusted depending on kidney function and liver function.
• Check interactions: Some interacting medicines can significantly increase ranolazine levels, which may require dose changes or avoidance.

Important: Your exact dose should be confirmed from the prescription label or packaging. Do not change your dose without medical advice.

Food interactions

Ranolazine can be taken with or without food, but certain dietary and timing habits may affect tolerance.

• With food: Some people find gastrointestinal side effects easier to manage when taken with a meal.
• Avoid sudden changes: Large changes in meal patterns may affect how you feel, even if food doesn’t strictly “stop” the medicine from working.
• Grapefruit and similar products: Foods or juices that strongly affect liver enzymes can increase medicine levels in some drugs. Discuss with your pharmacist whether you should avoid grapefruit-based products.

If you experience nausea, dizziness, or headaches, consider whether taking Ranexa with food (or adjusting meal timing) improves comfort.

Alcohol interactions

Alcohol can worsen dizziness, fatigue, and light-headedness—effects that may occur with ranolazine in some people.

• Recommendation: It’s best to limit alcohol and avoid heavy drinking.
• Watch for symptoms: If you feel unusually dizzy, faint, or your heart feels “different,” stop alcohol and seek advice.

Because each person’s health status and other medicines differ, your clinician or pharmacist can provide more tailored guidance.

Medicine interactions (very important)

Ranolazine levels and heart rhythm effects can be influenced by other medicines. Always provide a complete list of what you take (including “over-the-counter” products, supplements, and herbal remedies).

Common categories of interactions

• Medicines that affect heart rhythm (QT-prolonging drugs): Ranolazine can increase the QT interval. Combining it with other medicines that also prolong QT may increase risk.
• CYP3A inhibitors (can raise ranolazine levels): Some antifungals (e.g., certain azoles), some antibiotics (e.g., macrolides), and some HIV medicines may increase ranolazine concentration.
• CYP3A inducers (can lower effectiveness): Some seizure medications and other drugs may reduce ranolazine levels.
• Medicines affecting blood pressure or heart rate: Combination therapy may increase side effects like dizziness or low blood pressure.
• Other anti-anginals: Ranexa may be used with other angina medicines, but combinations should be monitored.

What to do

• Ask before starting new medicines: Even short-term antibiotics or antifungals can matter.
• Be cautious with supplements: Some “herbal” products can affect liver enzymes.
• Report symptoms promptly: Tell your healthcare professional if you get palpitations, fainting, or significant dizziness.

If you are unsure: A quick check by your pharmacist can help prevent harmful interactions.

Pharmacokinetics (how the body handles Ranexa)

Pharmacokinetics describes absorption, distribution, metabolism, and elimination. While this section is technical, it can help explain why dosing is structured the way it is.

Absorption and distribution

• Extended-release design: Ranexa is formulated to release ranolazine slowly, supporting steadier blood levels across the day.
• Steady-state: Blood concentrations generally reach steady levels after repeated dosing over a period of days.
• Protein binding: Ranolazine is substantially bound to plasma proteins.

Metabolism

• Hepatic metabolism: Ranolazine is mainly metabolised in the liver by enzyme pathways including CYP3A.
• Interaction relevance: This is why drugs that inhibit or induce CYP3A can significantly affect ranolazine exposure.

Elimination

• Excretion: Ranolazine metabolites are eliminated primarily via the kidneys (urine) and to a lesser extent through other routes.
• Kidney function matters: Reduced kidney function may increase exposure to ranolazine or its metabolites, requiring careful monitoring.

Clinical relevance: Because metabolism and clearance can vary, your dose and monitoring plan may change if you develop kidney or liver issues or start interacting medicines.

Safety profile: side effects and warnings

Like all medicines, Ranexa can cause side effects. Many are mild and improve over time, but some require prompt medical attention.

Common side effects

• Dizziness or light-headedness
• Headache
• Nausea
• Constipation
• Feeling tired or weakness

Less common but important risks

• QT prolongation: Ranolazine can affect electrical conduction in the heart. Risk increases with some interacting drugs, electrolyte abnormalities (low potassium or magnesium), and certain heart conditions.
• Serious dizziness or fainting: Can occur if your blood pressure drops or if there are rhythm-related effects.
• Hepatic (liver) impairment: People with significant liver problems may be at higher risk of side effects; dosing may be adjusted or avoided depending on severity.

Seek urgent medical help if

• You faint or nearly faint
• You experience severe dizziness, new severe palpitations, or chest symptoms that differ from your usual angina pattern
• You develop signs of an allergic reaction (swelling of face/lips, trouble breathing, widespread rash)

Tip: If you monitor your heart rate or blood pressure at home, note any significant changes and share them with your healthcare provider.

Practical use tips for everyday life

• Take it reliably: Use a phone alarm or medication organiser to maintain the twice-daily schedule.
• Consistency with meals: If you find food improves tolerance, make it a habit (e.g., take with breakfast and dinner).
• Keep a list of medicines: Include prescription, over-the-counter, vitamins, and supplements. Bring the list to appointments.
• Watch for dizziness: Be cautious when driving or operating machinery until you know how Ranexa affects you.
• Stay hydrated and eat regularly: This can help reduce light-headedness in some people.
• Don’t stop abruptly: If you need to discontinue due to side effects, do so under professional guidance.

Alternative options (talk to your clinician)

Chronic angina treatment often involves one or more of the following strategies. Choice depends on your symptoms, heart function, blood pressure, heart rate, comorbidities, and risk factors.

• Beta-blockers (reduce heart rate and workload)
• Calcium channel blockers (such as amlodipine or diltiazem-type drugs)
• Nitrates (short-acting for relief and longer-acting for prevention—exact approach varies)
• Other anti-anginal medicines depending on availability and your medical profile
• Revascularisation procedures in appropriate patients (angioplasty/stenting or bypass surgery)
• Lifestyle measures (smoking cessation, exercise plan, weight management, diet, and stress reduction)

Your clinician may tailor a combination approach based on how often you have symptoms and how your heart responds during daily activities.

Market and legal context for Australia

In Australia, the supply of prescription medicines is regulated to ensure safety and appropriate use. Access to ranolazine depends on clinical need and prescribing requirements under Australian medicines policy and state/territory health regulations.

In general:

• Pharmacist checks: Pharmacists review suitability, interactions, and dosing details before dispensing.
• Product information: Patients are encouraged to read the consumer medicine information (CMI) and follow label instructions.
• Safety monitoring: Clinicians may recommend ECG monitoring or blood tests in some situations, especially when multiple heart-related medicines are used.

For specific availability, subsidisation and brand listings, your pharmacist can advise based on the latest information for your region and circumstances.

Recent guidance and monitoring considerations

While guidance can evolve, key ongoing safety themes relevant to ranolazine include:

• Electrocardiogram (ECG) awareness: Because QT prolongation risk can be influenced by other medicines and patient factors, clinicians may consider ECG review when starting or adjusting therapy.
• Medication reconciliation: Many interaction-related concerns are prevented by carefully reviewing current medicines, including newly started antibiotics/antifungals.
• Electrolyte balance: Low potassium or magnesium (e.g., from certain diuretics or illnesses causing vomiting/diarrhoea) may increase rhythm risk.

If you’ve had recent changes in your health—such as kidney function changes, new medications, or electrolyte disturbances—notify your healthcare professional promptly.

Delivery and availability (online pharmacy information)

Availability can vary by brand supply and tablet strength. Most Australian online pharmacies can:

• Confirm stock for the specific product strength you need
• Pack securely to protect tablets from moisture and damage
• Deliver to your address with tracking (timing depends on location and courier service)

Delivery timeframes vary. At checkout, you’ll typically see estimated dispatch and delivery windows. If your required strength is temporarily unavailable, the pharmacy may contact you with alternatives (subject to clinical appropriateness) or estimated restock dates.

Quick reference: key facts at a glance

FAQ – Ranexa (Ranolazine)

1) Is Ranexa for sudden chest pain relief?

No. Ranexa is generally used to manage chronic/stable angina over time. It is not designed as an immediate “rescue” medicine for sudden chest pain. If you experience sudden chest pain, follow your angina action plan and seek urgent medical advice as directed by your healthcare professional.

2) How long does it take to work?

Some people notice symptom improvement after starting treatment, but it may take days to weeks to achieve full benefit. Continue taking it consistently and discuss progress at follow-up visits.

3) Can I take Ranexa with food?

Yes. Ranexa can usually be taken with or without food. If you get nausea or stomach discomfort, taking it with a meal may help.

4) What if I forget a dose?

Take it when you remember unless it’s close to the next scheduled dose. Do not double doses to catch up. If you’re unsure, ask your pharmacist.

5) Are there medicines I must avoid?

Some medicines can significantly interact with ranolazine—especially those that affect the heart’s rhythm or change ranolazine levels via CYP3A pathways. Share your full medicine list with your pharmacist before starting or stopping any medicine.

6) Does Ranexa affect driving or machinery?

Some people may experience dizziness or tiredness. Until you know how Ranexa affects you, use caution with driving, ladders, or machinery.

7) Can I drink alcohol while taking Ranexa?

It’s safest to limit alcohol. Alcohol may increase dizziness or tiredness and may worsen overall tolerance. If you feel light-headed or unwell after drinking, stop alcohol and seek advice.

8) What should I do if I have palpitations or feel faint?

Stop what you are doing, seek urgent medical advice, and do not ignore symptoms like fainting, severe palpitations, or severe dizziness—especially if new or unexplained.

9) Does kidney or liver disease change how Ranexa is used?

Yes. Kidney and liver function can affect ranolazine exposure and safety. Your clinician may adjust the dose or use extra monitoring.

10) What are common alternatives if Ranexa isn’t suitable?

Depending on your health profile, alternatives may include other anti-anginal medicines (such as beta-blockers, calcium channel blockers, and nitrates) or procedural options in selected cases. Your clinician can recommend what fits best.

Reminder: This information is designed to help you understand Ranexa (ranolazine) and manage it safely. It does not replace advice from your healthcare professional or the Consumer Medicine Information (CMI) provided with your product.